Abstract:
Novel compound of the formula: ##STR1## wherein R.sup.1 is pyridyl group, R.sup.2 is a phenyl group, a thienyl group, a furyl group, a naphthyl group, a benzothienyl group or pyridyl group, which may optionally have a lower alkoxy group, a lower alkyl group, a halogen atom, trifluoromethyl group, a lower alkenyl group or methylenedioxy group, R.sup.3 is hydrogen atom or a lower alkyl group, and n is an integer of 0 to 6, Y is sulphur atom, methylene group or a group of the formula: ##STR2## wherein R.sup.4 is hydrogen atom or acetyl group, and m is 0 or 1, and their pharmaceutically acceptable salts having an inhibitory action on bio-synthesis of thromboxane A.sub.2 (TXA.sub.2) and an effect of accelerating the productivility of prostaglandin I.sub.2 (PGI.sub.2), and can be used for mammals to the prophylaxis or therapy of thrombosis caused by platelet aggregation or ischemic diseases caused by vasospasms in cardiac, cerebral and peripheral circulatory system (e.g. cardiac infarction, apoplexy, infarct of blood vessels in kidney, lung and other organs, pectic ulcer, etc.).
Abstract:
A method for producing a lactam having the formula: ##STR1## wherein R.sup.1 is a hydrogen atom, or a straight chain or branched chain alkyl group having from 1 to 5 carbon atoms, and R.sup.2 is an organic group having at least 2 carbon atoms, and connected at both ends to the cyclic acid imide group, which comprises reducing a cyclic acid imide having the formula: ##STR2## wherein R.sup.1 and R.sup.2 are as defined above, or its precursor, with hydrogen by means of a cobalt-based catalyst comprising (a) cobalt and (b) at least one modifier component selected from the group consisting of molybdenum, tungsten and rhenium.
Abstract:
Caprolactam is prepared by a process in which(a) the 5-formylvalerate is reacted with excess ammonia and hydrogen in the presence of an alkanol as the solvent and in the presence of a hydrogenation catalyst under superatmospheric pressure in the liquid phase at from 40.degree. to 130.degree. C.,(b) excess ammonia and hydrogen are separated off from the reaction mixture,(c) the resulting reaction mixture is reacted with water at elevated temperatures with simultaneous removal of alkanols, and(d) the reaction mixture thus obtained is heated to 150.degree.-370.degree. C. and .epsilon.-caprolactam is obtained.
Abstract:
Caprolactam is prepared by a process in which(a) a 5-formylvalerate is reacted with excess ammonia and hydrogen in the presence of an alkanol as a solvent and in the presence of a hydrogenation catalyst under superatmospheric pressure in the liquid phase at from 40.degree. to 130.degree. C.,(b) excess ammonia and hydrogen are separated off from the reaction mixture and(c) the reaction mixture thus obtained is heated to 150.degree.-250.degree. C. and .epsilon.-caprolactam is obtained.
Abstract:
Caprolactam is obtained in high yield and in short reaction time by completely dissolving 6-aminocaproic acid in methanol or ethanol and heating the solution at 170.degree.-200.degree. C.
Abstract:
Alkyl-substituted unsaturated .delta.-lactams are obtained by contacting monocyanoethylated ketones with an aqueous acid solution and permitting them to react. Alkyl-substituted unsaturated .delta.-lactams of this invention are valuable intermediate products useful for organic synthesis in the production of pharmaceuticals and plastics.
Abstract:
A method of cleaving ketones at a carbon-carbon bond adjacent to the ketonic carbon to produce a terminal carboxylic ester and a terminal oxime group, which comprises, nitrosating the ketone in the presence of a polar aprotic solvent and an alcohol. The products are useful intermediates, particularly as intermediates in the production of polyamides, and as solvents. A method of synthesizing Epsilon -caprolactam from the intermediate omega hydroximino hexanoate, produced by cleaving cyclohexanone, hydrogenating the intermediate omega -aminohexanoate ester and cyclizing the corresponding ester thus formed, to Epsilon caprolactam.
Abstract:
An improved process for preparing 2-pyrrolidinone at relatively low pressures which comprises reduction of succinimide in an aqueous system at temperatures of about 225* to 275* C., at a pressure in the range of about 1,200 to 1,500 p.s.i.g. and in the presence of a supported palladium catalyst.
Abstract:
E-AMINOCAPROIC ACID IS PRODUCED BY THE HYDROLYTIC DECOMPOSITION OF E-CAPROLACTAM WHEREIN A MIXTURE OF THE LACTAM AND BA(OH)2$8H2O IS DISSOLVED IN A MIXED SOLVENT CONSISTING OF WATER AND DIMETHYLSULFOXIDE (DMSO). THE BARIUM SALT OF THE ACID WHICH IS FORMED IS THEN CONVERTED TO THE FREE ACID BY ADDING GASEOUS CARBON DIOXIDE WHICH FORMS INSOLUBLE BACO3.